Issue 01 May 2026 How buildings shape the people inside them

Reports  /  Healthcare's quiet building turn

Healthcare

exploratory

Healthcare's quiet building turn

What the built environment contributes to therapy.

By Christian Huser, in The Built Review · 20 Mar 2026 · 11 min read · 11 named sources

Evidence status as of 20 Mar 2026 · Version 1

Situation

Hospitals are planned by efficiency parameters. Square meters and bed count drive the investment calculation. Hygiene and fire safety decide the permit. The room as a factor on patients and staff does not show up in the planning model.

An evidence base from 2005 to 2025 documents this factor anyway. Walch and colleagues compared 89 patients after spine surgery on the bright and the dark sides of the same hospital ward in a 2005 prospective cohort study (Walch et al., 2005, Psychosomatic Medicine 67(1):156-163). The bright side received 46 percent more sunlight. Patients on the bright side needed 22 percent fewer analgesics per hour at p=0.047, their analgesic costs ran 21 percent lower at p=0.047, and reported stress was lower. The design is a prospective cohort, not a randomized trial, but it measures the economically relevant endpoint directly.

Al Khatib, Samara and Ndiaye published a systematic review of the field in 2024, run on a PRISMA protocol with a bibliometric component (Al Khatib et al., 2024, Frontiers in Built Environment). The search covered literature from 2010 to 2023 on biophilic design in hospitals. The reported associations with shorter length of stay are directionally consistent across the included studies. The same holds for postoperative pain demand and for staff stress, in both cases with methodological heterogeneity in the underlying primary studies. Where the primary studies document effect magnitudes robustly, those magnitudes do not support every marketing claim of the biophilic design industry.

Tekin, Corcoran and Urbano Gutiérrez published a meta-synthesis of the qualitative data from the Maggie’s Centres in the UK in 2023 (Tekin et al., 2023, Frontiers of Architectural Research 12(1):188-207). Maggie’s are an institutional special case of cancer-companion architecture. Maggie Keswick Jencks died in 1995. The first centre opened in Edinburgh in 1996. About two dozen houses now exist, most of them in the UK and some abroad in Hong Kong, Tokyo, Barcelona and Groningen. They are not clinical architecture. They are house-like buildings with gardens and daylight, places that cancer patients can visit between treatments.

Youn, Kang and Lee used functional near-infrared spectroscopy in 2025 to measure what happens in the brains of nurses who spend ten minutes in a fully greened room against a white-walled control room (Youn et al., 2025, IJERPH 22(10):1571). Across 21 nurses at a hospital in Cheon-An, South Korea, oxygenation in the dorsolateral prefrontal cortex dropped significantly in the greened room at p<0.001. The sample is small but the measured mechanism is plausible: the brain had less regulation to perform in the quieter setting.

The DRG logic runs across all of this. Inside the German case-payment system, inside comparable European systems and inside the US Diagnosis-Related-Groups billing, a shorter length of stay translates directly into the cost per case. Staff turnover acts as its own cost factor in the current nursing shortage. Both magnitudes appear in the biophilic literature as outcomes, but the translation into the institutional calculation of the hospital itself is still missing.

Finding

The economically translatable effects fall first on postoperative pain demand, which feeds directly into the medication and complication costs inside the case-payment envelope. The length of stay sits next to that on the revenue side of the case payment, and in a market with a chronic nursing shortage the stress load on staff becomes its own cost factor through absence and vacancy.

Walch 2005 is the hard pain anchor in this line. The 22 percent reduction in analgesics per hour and the 21 percent reduction in analgesic costs at p=0.047 are not marketing magnitudes. They are data from a prospective cohort. The study measures the effect of sun exposure, not of greening or material choice, and what it says about daylight is solid.

Tekin and colleagues delivered the qualitative validation at an established special case in 2023. Daylight stood at the top for patients in the Maggie’s meta-synthesis, with fresh air and greenery close behind. For staff, privacy and quiet led instead. Patients prioritized these room factors over the strictly medical service of the Centres. The statement is qualitative, not an RCT effect, but it lines up with the economically measurable daylight effect in Walch.

Youn 2025 adds a neurophysiological hint. The drop in dlPFC oxygenation points to reduced cognitive load. Linking Youn’s mechanism hint to Walch’s measured outcome is a conjecture, not a demonstrated pathway. Youn measured nurses in a greened setting, Walch measured patients under daylight, so the populations and the interventions differ. What stays plausible is that the brain spends less regulatory capacity in a quieter setting and leaves more room for other processes. The effect is documented in Walch’s economic endpoints and in Youn’s neurophysiological measure. The common mechanism is an open research question.

A tension has to stand here. The same architectural feature that measurably eased the workload on nurses in Youn’s experiment can also bring an infection risk inside a hospital. Surial and colleagues measured a vertical green wall in a Swiss hospital in 2021 and documented elevated concentrations of bacteria and fungi in the surrounding air, on the wall surface itself and in the irrigation water that fed the plants, including Aspergillus niger and Aspergillus terreus (Surial et al., 2021, Infection Control & Hospital Epidemiology 43(2):273-275). Their own words: “the elevated concentrations of microorganisms in the air, on the plant wall, and in the water of this vertical garden led the hospital’s infection prevention committee to forego any further indoor plant installations.” The committee dropped further indoor planting after the measurement.

The two findings do not contradict each other directly. They show that a single intervention in biophilic design, the green wall, can simultaneously ease cognitive load and bring an infectious microbiome that matters in a hospital setting. The institutional consequence is not a blanket decision for or against greening, but a differentiated approach by patient group and location. Sehulster and Chinn set this out for the Centers for Disease Control and Prevention in 2003 in the HICPAC guideline (Sehulster and Chinn, 2003, MMWR Recommendations and Reports 52(RR-10)). Fresh and dried flowers and potted plants are forbidden there in patient areas for immunosuppressed patients as a Category II recommendation. For immunocompetent patients they remain permitted, also as a Category II recommendation. The rule is a graded restriction rather than a blanket ban.

The evidence on daylight, view and outdoor access is not touched by the Surial finding. It is a different class of intervention with a different risk profile.

The evidence has other limits the report has to name. Bulaj, Forero and Huntsman published a 2025 perspective paper in Frontiers in Medicine formulating biophilic design as a modulatory hypothesis on the psychopharmacological response (Bulaj et al., 2025, Frontiers in Medicine). The paper is explicitly not a systematic review and not an RCT. It provides no primary data of its own. Its focus is on therapeutic home environments, not on the hospital setting. The modulation claim in this form carries no institutional calculation and remains an open research question.

The small sample in Youn 2025 is also a limit. 21 nurses do not carry a generalization step. And the Al Khatib review, systematic in protocol, still draws on primary studies whose quality varies across the included papers. Correlation and causation are not consistently separable in this material.

My own position stands nevertheless. The evidence base does not support every marketing claim from the biophilic design industry, but it supports an institutional consequence. Anyone who plans or finances hospitals can take the documented effects as a quantifiable factor in the investment calculation, with the uncertainty marked. Anyone operating a house can put the same factor on staff load and its downstream cost. Today neither group does this.

Research context

The academic translation of this material into health-economics models is still pending. Al Khatib 2024 delivers the field overview, Tekin 2023 the qualitative validation at the Maggie’s Centres. Youn 2025 adds a first neurophysiological mechanism through the measured dlPFC activity. Walch 2005 and Ulrich 1984 stand alongside them as older but hard anchors.

Roger Ulrich showed in Science in 1984 that postoperative patients in hospital rooms with a view of trees had shorter stays and required less potent analgesics than patients facing a brick wall (Ulrich, 1984, Science 224(4647):420-421). The finding has held up across many replications. It sits at the start of the line in which Walch and the newer work stand.

Several gaps remain open. No published comparison of DRG case costs exists between biophilically designed and conventionally equipped hospitals. The existing economic estimates derive extrapolated savings from length-of-stay reductions without performing the calculation directly. The gap is methodologically solvable but it is not solved.

No randomized trial exists for the Bulaj modulation thesis in the hospital setting either. The nearest cohort evidence comes from Walch on analgesic demand under daylight and from Ulrich on analgesic demand under a nature view. Both support the modulation conjecture at the cohort level without replacing an RCT.

A third gap concerns the capital market. No major healthcare REIT names biophilic design as a stand-alone investment criterion across its holdings. Welltower has built the welltowerLIVING brand, but the brand targets wellness housing in the senior segment, not the hospital setting. Institutional investors have not adopted the biophilic line as a portfolio criterion.

These findings sit inside an older line. Beatley, Jones and Rainey edited a 2018 overview of the healing-environments debate, “Healthy Environments, Healing Spaces” (University of Virginia Press). Shan Jiang reviewed the Chinese literature on therapeutic landscapes and healing gardens against the Western research in 2014 (Jiang, 2014, Frontiers of Architectural Research 3(2):141-153). The newer empirical work has made the material methodologically denser without changing the underlying assumption.

Consequence

For healthcare REITs and private hospital operators. No major REIT runs biophilic design as a portfolio criterion for its hospital line today. Welltower’s welltowerLIVING brand shows that wellness as a differentiation lever is institutionally recognized in the senior segment. It has not yet crossed into the hospital portfolio. Whoever spends the next two years collecting pilot data from their own holdings and benchmarking it against comparison groups holds, by 2028 or 2029, an investment argument that competitors do not have. Technically the move is straightforward. What it requires is the willingness to run an outcome comparison that current REIT reporting does not yet expect.

For public hospital trusts. The Walch figures reach 22 percent on analgesic demand and 21 percent on analgesic cost, and the Al Khatib corpus and the Maggie’s material point the same way. Many of the individual moves, like window placement and daylight ingress, sit inside the planning envelope already. Direct outdoor access on the recovery side is structurally harder, but it is among the most highly rated factors in the Maggie’s data. The argument belongs in the DRG negotiation, not only in the architectural competition. A trust that can demonstrate a measurable effect on length of stay or on analgesic demand carries a lever into the case-payment argument. The Walch figures allow a first approach. They do not replace a house-specific audit.

For nursing organizations and personnel representation. Shepley and colleagues reported in 2012 from a quasi-experimental before-after comparison of two intensive care units in New Hampshire that mean staff absence fell from 38 to 23 hours per person, with average vacancy roughly 25 percent lower in the new daylight-supplied unit (Shepley et al., 2012, HERD 5(2):46-60). The design is a quasi-experiment, the daylight effect is confounded with other changes between the old and the new ward, and the significance is borderline at p=0.05. Even with that caveat, Youn 2025 adds a neurophysiological mechanism in the same direction. The findings belong in pay and structural negotiations on working conditions, including in places where the architectural competition does not have personnel in view. Staff load is an economic variable as much as a social one.

For the pharmaceutical industry, in a conditional reading. The Bulaj modulation thesis is not proven. Walch on daylight and Ulrich on a nature view support it at the cohort level without proving it. If the thesis holds, the heterogeneity of the spatial setting in phase-III studies would produce an effect-dilution risk. The consequence would be to systematically record spatial variables like daylight exposure and visual contact with nature in study protocols, with the acoustic setting as a separate methodological block. Folding that into the next study generations protects against a distortion that the current study design does not control for. This recommendation stands under the proviso that the modulation thesis is confirmed in a randomized trial. Until that point it is a study-design question that should become visible in the methods sections of the next phase-III publications.

Sources

  1. Walch et al., 2005, Psychosomatic Medicine 67(1):156-163. 89 spine-surgery patients, bright vs dark side; −22 % analgesics per hour (p=0.047).
  2. Al Khatib, Samara and Ndiaye, 2024, Frontiers in Built Environment. Systematic review (PRISMA) with bibliometric component, biophilic design in hospitals, 2010–2023.
  3. Tekin, Corcoran and Urbano Gutiérrez, 2023, Frontiers of Architectural Research 12(1):188-207. Meta-synthesis of qualitative Maggie's Centres data.
  4. Youn, Kang and Lee, 2025, IJERPH 22(10):1571. 21 nurses, fNIRS dlPFC oxygenation, greened room vs control (p<0.001).
  5. Surial et al., 2021, Infection Control & Hospital Epidemiology 43(2):273-275. Vertical green wall, elevated bacteria and fungi including Aspergillus.
  6. Sehulster and Chinn, 2003, MMWR Recommendations and Reports 52(RR-10). HICPAC guideline; Category II restriction on plants in immunosuppressed-patient areas.
  7. Bulaj, Forero and Huntsman, 2025, Frontiers in Medicine. Perspective on biophilic design as modulatory hypothesis; not a systematic review.
  8. Shepley et al., 2012, HERD 5(2):46-60. Quasi-experimental ICU before-after; mean staff absence 38 → 23 hours per person.
  9. Ulrich, 1984, Science 224(4647):420-421. Postoperative recovery and view of trees.
  10. Beatley, Jones & Rainey (eds.), 2018, "Healthy Environments, Healing Spaces", University of Virginia Press. Overview of the healing-environments debate.
  11. Jiang, 2014, Frontiers of Architectural Research 3(2):141-153. Review of Chinese vs Western literature on therapeutic landscapes and healing gardens.

PDF edition available on request · editor@thebuiltreview.com